The global cell & gene therapy manufacturing services market size is projected to reach USD 13.8 billion by 2026 from USD 7.7billion in 2021, at a CAGR of 12.4%

Ads

You May Also Like

pSivida Corp. Provides Company Update and Reports Second Quarter FY 2016 Results

WATERTOWN, Mass., Feb. 08, 2016 (GLOBE NEWSWIRE) -- pSivida Corp. (NASDAQ:PSDV), (ASX:PVA),  a leader ...

Kura Oncology to Report Second Quarter 2018 Financial Results

SAN DIEGO, July 30, 2018 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (Nasdaq: KURA), a ...